We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read morePharmaceutical companies are incorporating payer / HTA needs into their clinical and commercial laun...
Read moreThis study aims to understand the industry perspective on drivers and challenges for a successful la...
Read morePharmaceutical pricing and market access is the crucial challenge for successful product launch toda...
Read moreReview of secondary literature and clinical trial databases to understand payer willingness to pay.
Read more13 market-changing drugs are expected to hit the European market this year and these blockbusters re...
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...
Read moreDevelopment and implementation of the optimum price submission strategy for a product in the EU.
Read moreIncluded in this issue is the implications for the UK market regarding Brexit and how the UKs CDF pe...
Read moreThe lack of a biosimilar market in the US is largely due to the substantial patent litigations which...
Read more